US equities
|
NVDA
$162.85
▼-2.01%
AMD
$534.06
▼-8.75%
MU
$778.31
▼-2.52%
AAPL
$356.27
▲+0.39%
MSFT
$523.88
▲+0.17%
TSLA
$390.22
▼-1.82%
AVGO
$347.01
▼-4.76%
SNDK
$885.01
▼-5.59%
NVDA
$162.85
▼-2.01%
AMD
$534.06
▼-8.75%
MU
$778.31
▼-2.52%
AAPL
$356.27
▲+0.39%
MSFT
$523.88
▲+0.17%
TSLA
$390.22
▼-1.82%
AVGO
$347.01
▼-4.76%
SNDK
$885.01
▼-5.59%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Mindbloom
Recent news which mentions Mindbloom
EXCLUSIVE: Mindbloom's Mastermind Series, A Psychedelic Therapy Program For Heartbreak, Burnout & Parallel Challenges
November 29, 2023
Tags
Interview
News
Management
From
Benzinga
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
January 21, 2023
Tickers
AMZN
CLABF
OPTHF
TRUFF
Tags
News
Cannabis
Psilocybin Microdosis
From
Benzinga
At-Home Ketamine For Depression: New Study Adds Proof On Its Safety And Efficacy
July 19, 2022
Tags
Mindbloom
Market News
Ketamine Therapy
From
Benzinga